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Background: Acute kidney injury (AKI) is an independent risk factor for mortality and is responsible for a significant
burden of healthcare expenditure, so accurate measurement of its incidence is important. Administrative coding
data has been used for assessing AKI incidence, and shows an increasing proportion of hospital bed days
attributable to AKI. However, the accuracy of coding for AKI and changes in coding over time have not been
studied in England.
Methods: We studied a random sample of admissions from 2005 and 2010 where ICD-10 code N17 (acute renal
failure) was recorded in the administrative coding data at one acute NHS Foundation Trust in England. Using the
medical notes and computerised records we examined the demographic and clinical details of these admissions.
Results: Against a 6.3% (95% CI 4.8-7.9%) increase in all non-elective admissions, we found a 64% increase in acute
renal failure admissions (95% CI 41%-92%, p < 0.001) in 2010 compared to 2005. Median age was 78 years (IQR 72–
87), 11-25% had a relevant pre-admission co-morbidity and 64% (55-73%) were taking drugs known to be
associated with AKI. Over both years, 95% (91-99%) of cases examined met the Kidney Disease: Improving Global
Outcomes criteria for AKI.
Conclusions: Patients with hospital admissions where AKI has been coded are elderly with multiple co-morbidities.
Our results demonstrate a high positive predictive value of coding data for a clinical diagnosis of AKI, with no
suggestion of marked changes in coding of AKI between 2005 and 2010.
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Acute kidney injury (AKI), previously called acute renal
failure, is a sudden reduction in kidney function which
can be due to a wide range of conditions including severe
infection and hypovolaemia, or in response to certain
drugs and toxins. Although AKI may result in complete
recovery of kidney function, many patients require tem-
porary dialysis or haemofiltration and prolonged hospital
stay, and it is associated with a substantial mortality [1].
The net result is a significant burden on healthcare ex-
penditure [2].
Despite the clinical importance of AKI, there are lim-
ited data to assess its incidence. Many large studies have* Correspondence: lat42@cam.ac.uk
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distribution, and reproduction in any mediumused case definitions based on biochemical values and
changes in urine output which are the gold-standard but
have been complicated by changing definitions over time
and may be logistically complex to analyse [3,4]. Other
studies have used electronically recorded diagnostic
codes such as the International Classification of Diseases
(ICD), to quantify the burden of AKI [5,6]. In England,
this data is available from Hospital Episode Statistics
(HES), a database containing details of all admissions to
National Health Service hospitals [7]. HES contains ad-
ministrative details which have been electronically
recorded for the vast majority of hospital admissions in
England including diagnostic information, currently
coded using the 10th edition of ICD (ICD-10). Such data
is widely used for health services research, particularly
where no biochemical information is available such as
within primary care databases. Such research is important:tral Ltd. This is an Open Access article distributed under the terms of the
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hospital bed days attributable to AKI has increased rapidly
over the last 4 years [8] and these results have been used
to argue for significant changes to health services and in-
creased investment in care for AKI [9]. However, the ap-
parent increase in hospital admissions due to AKI may be
due to patients being wrongly coded, or to a change in
clinical administrative practices, where patients are coded
with AKI for a less severe kidney insult than previously.
This could occur due to increased awareness of the condi-
tion, or result from ‘gaming’, since hospitals are remuner-
ated according to patient codes. Therefore understanding
the validity of such coding is vital but few studies have
been conducted to examine the validity of diagnostic
codes for AKI [10]. In particular, these have not been
conducted in a United Kingdom setting and do not reflect
changes over time. We therefore chose to examine in de-
tail the clinical and biochemical characteristics of repre-
sentative samples of patients who had an admission coded
as AKI from two calendar years, 2005 and 2010 and to de-
termine whether these patients did have AKI based on
current criteria.
Methods
Data obtained from HES for a hospital admission is
comprised of one or more consecutive “episodes” of care
(a period of care under a specific clinician). Each episode
records a primary diagnosis (the main condition treated
or investigated during this episode) and up to 19 add-
itional secondary diagnoses.
We obtained a list of adult admissions to Addenbrooke’s
Hospital in Cambridge, England during the full calendar
years 2005 and 2010, where ICD-10 code N17 (acute renal
failure) was listed in any diagnostic position in any admis-
sion episode. Since ICD-10 was introduced, the term AKI
has largely replaced acute renal failure in clinical use but
this has not yet been amended for coding purposes.
Where multiple admissions for one individual occurred
within the same year, only the first admission was in-
cluded. We obtained a random sample of the admissions
for both years and the same observer (AMR), an experi-
enced clinician who was blinded to the study hypothesis,
examined all relevant clinical records. Sample size was
pragmatically chosen to enable a moderately precise esti-
mate of patient characteristics, but without the power to
detect differences between years. Patients who had been
on dialysis or had a renal transplant prior to the relevant
admission were excluded. The observer completed a pre-
defined detailed summary of the demographic and clinical
admission details, accessing additional computerised la-
boratory records where necessary.
We recorded the presence of a number of co-
morbidities (diabetes, hypertension, cardiovascular disease
and heart failure) based on a diagnosis made prior toadmission and recorded in the hospital notes or general
practitioner (GP) referral letter. Baseline estimated glom-
erular filtration rate (eGFR) was calculated from the low-
est recorded value of creatinine in the three months prior
to admission, or the last recorded value prior to this if no
measurements were available during this period, using the
4-variable MDRD equation [11]. Since eGFR is not appro-
priate for assessment of renal function during episodes of
AKI we quantified admission renal function using the first
value of creatinine from a biochemistry sample analysed
by the hospital pathology laboratory. All samples were
measured within 24 hours of admission. Bicarbonate was
the first recorded sample taken on the day of admission,
whether taken from an arterial or venous blood gas sam-
ple. Systolic blood pressure was as recorded on the emer-
gency department triage card or in the initial medical or
nursing assessment. Recent diarrhoea or vomiting was
recorded if a relevant history was given by the patient of
either or both symptoms in the week preceding admission.
We derived the pre-admission drug history from informa-
tion recorded from the patient, GP letter or subsequently
documented by a pharmacist in the medical notes after li-
aison with the GP practice. We evaluated drugs that are in
common use in the community and known to be associ-
ated with AKI [12,13].
The observer compared the biochemical details of the
entire admission to any of the Kidney Disease: Improv-
ing Global Outcomes (KDIGO) definitions of acute kid-
ney injury (AKI) [14]. These were an increase in serum
creatinine by ≥26.5 μmol/l within 48 hours, an increase
in serum creatinine to ≥1.5 times baseline, an increase in
serum creatinine to ≥354 μmol/L or commencement on
renal replacement therapy, having met another definition
of AKI. We also examined the criteria for urine output
but biochemical and urine definitions were concordant
and there were no situations where a case was defined
by urine output alone. If the details of the admission
were consistent with the KDIGO definition, the admis-
sion was defined as accurately coded.
This project was designated by Cambridge University
Hospitals NHS Trust to be a service evaluation so individ-
ual informed patient consent was not required and ethical
committee approval was not needed. Only one study team
member (LAT) and the observer had access to identifiable
patient information and this was kept confidential at all
times. All other study members examined anonymised pa-
tient data only.
On inspection we found many continuous data items
have had non-normal skewed distributions and so all
such data are summarised as median (interquartile
range, IQR). Dichotomous variables are presented as
number and frequency with 95% confidence intervals
(95% CI). Changes in admission rates were derived from
Poisson regression with year as the only covariate.
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Numbers of admissions
There was a relatively small increase (6.3%, 95% confi-
dence interval 4.8-7.9%) in non-elective admissions to
Addenbrooke’s Hospital between 2005 and 2010, from
35,472 to 37,720. However, there was a disproportionate
increase in AKI admissions (ICD-10 code N17 in any
diagnostic position) from 261 to 429 (64%, 41-92%). 116
patients (44%, 38-50%) had the code N17 recorded in
the primary diagnostic position, rather than a secondary
diagnostic position, in 2005. Similar findings were ob-
served in 2010 (44%, 39-48%). We examined 58 case
notes from 2005 and 63 from 2010.
Patient characteristics
Details of patients’ characteristics for each year are
shown in Table 1. Across both years, the median age ofTable 1 Summary of patient details
2005
N (%)
Number of records examined 58 (100%)
Died during admission 30 (50%)
Male gender 21 (36%)
Diabetic 25 (43%)
Hypertensive 18 (31%)
Previous IHD or CVD 11 (19%)
Heart failure 13 (22%)
Recent diarrhoea/vomiting 11 (19%)
Admitted to ITU 10 (17%)
Haemodialysis/haemofiltration 29 (50%)
Pre-admission drug treatment
ACE Inhibitor 19 (35%)
ARB 5 (9%)
Loop diuretic 29 (55%)
Thiazide diuretic 5(9%)
NSAID 6 (11%)
Spironolactone 8 (15%)
Median (I
Age (years) 79 (70–8
Biochemical variables
Baseline eGFR (ml/min/1.73m2) 49 (29–6
Baseline creatinine (μmol/L) 120 (90–1
Admission creatinine (μmol/L) 265 (178–
Admission potassium (mmol/L) 5.0 (4.3-6
Admission bicarbonate (mmol/L) 17.2 (12.9-
Admission systolic BP (mmHg) 122 (105–
Count data are expressed as % (N), with 95% CI. Continuous data are expressed as
Intensive therapy unit; eGFR estimated glomerular filtration rate; ACE Angiotensin C
Non-steroidal anti-inflammatory drug.patients was 78 years (IQR 72–87) and 48% (95% CI 39-
57%) of patients were male. Rates of diabetes, hyperten-
sion, cardiovascular disease and heart failure were 30%
(95% CI 22-38%), 38% (95% CI 29-47%), 31% (95% CI
22-39%) and 16% (95% CI 9-22%) respectively. Overall,
64% (95% CI 55-73%) of patients were on at least one drug
that can increase the risk of AKI, and 22% (95% CI 15-30%)
of patients had suffered from recent diarrhoea/vomiting.
Median admission systolic pressure was 124 mmHg
(IQR 107–143) across both years. Baseline creatinine
was available in 52 records (88%) for 2005 and 58 re-
cords (94%) for 2010. Median baseline creatinine was
120μmol/L (IQR 90–160), with corresponding median
baseline eGFR of 47ml/min/1.73m2 (IQR 32–64). Ad-
mission creatinine was only missing from one record in
each of 2005 and 2010, median 257μmol/L (IQR 188–
420) across both years. Bicarbonate was only available2010
95% CI N (%) 95% CI
63 (100%)
37-63% 29 (46%) 33-59%
23-49% 15 (24%) 13-35%
30-56% 21 (33%) 21-45%
19-43% 19 (30%) 19-42%
9-29% 8 (13%) 4-21%
11-33% 14 (22%) 12-33%
9-29% 9 (14%) 5-23%
7-27% 9 (14%) 5-23%
37-63% 29 (46%) 33-59%
22-48% 14 (23%) 12-34%
1-17% 9 (15%) 6-24%
37-63% 18 (29%) 17-40%
1-16% 3 (5%) 0-10%
2-19% 3 (5%) 0-11%
5-24% 6 (10%) 2-18%
QR) Median (IQR)
5) 83 (73–88)
2) 45 (33–65)
70) 120 (90–155)
405) 252 (191–435)
.0) 4.5 (4.1-5.9)
21.1) 21.5 (16.8-26.1)
143) 127 (111–145)
median (IQR). IHD ischaemic heart disease; CVD cerebrovascular disease; ITU
onverting Enzyme; BP blood pressure; ARB Angiotensin Receptor Blocker; NSAID
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2010, median 21mmol/L (IQR 16–25) across both years.
Overall, 17% (95% CI 10-23%) of patients required ad-
mission to the intensive care unit, 16% (95% CI 9-22%)
received haemodialysis or haemofiltration, and 49% (95%
CI 40-58%) died during admission.
Accuracy of coding
In total, over both years, the percentage of cases meeting
the KDIGO criteria for AKI (positive predictive value) was
95% (95% CI 91-99%). Rates were similar for 2005 (95%,
95% CI 89-100%) and 2010 (94%, 95% CI 88-100%). The
positive predictive value for patients who survived to dis-
charge across both years was 95% (95% CI 90-100%).
Discussion
The main finding of this study is that the accuracy of
coding of AKI is very good, with 95% of cases meeting
the KDIGO definition. The high positive predictive value
for diagnosis is consistent with previous American stud-
ies which found a value of 94% for the ICD-9 code for
acute renal failure requiring dialysis [15] and 99% for
‘renal failure’ [16].
Our results also show that there has been a 64% in-
crease in admissions with acute renal failure coded as ei-
ther a primary or secondary diagnosis in 2010 compared
to 2005. No English data are available for comparison
but our findings are consistent with an increase in the
percentage of bed days attributable to AKI over that
time period and increased admissions described in
America [8,17]. It is unclear if our results reflect a true
increase in incidence or are due to greater recognition of
AKI, with a higher proportion of true cases being identi-
fied by coding in 2010. The study was not designed or
powered to detect differences in patient characteristics
between the two years examined. Indeed, we found no
statistical evidence (results not shown) of substantial dif-
ferences in patient characteristics, biochemical parame-
ters, clinical outcomes or pre-admission drug use
patterns between 2005 and 2010. However, it is worth
noting that biochemical values and complication rates
may be suggestive of lower disease severity in 2010 than
in 2005; a larger sample size would be required to con-
firm this. Alternately, improved early diagnosis and man-
agement of patients with AKI may contribute to these
differences [18].
Strengths of this study are the use of a representative
sample of cases admitted to a large teaching hospital,
reviewed in detail in a blinded manner by an experienced
clinician, and detailed characterisation of the patients.
There are important limitations however, including its
retrospective nature, limited size and restriction to the
coding practice of a single centre. The inpatient mortality
of this sample is higher than that seen nationally [5], andthe results may therefore not be generalizable to a less ser-
iously ill population. This may in part reflect ease of
obtaining notes since case records of deceased and living
patients are kept separately. The proportion of deceased
patients could bias our results if patients were more likely
to be wrongly coded depending on whether they lived or
died. However, the positive predictive value of a code of
AKI for the KDIGO definition among patients who sur-
vived to discharge across both years was the same as seen
in the whole cohort, suggesting that substantial bias is un-
likely to have occurred.
Data were not complete for every case examined al-
though overall the amount of missing data was small.
Although the observer was blinded to the hypothesis,
she was not blinded to the attributed code which may
have resulted in bias to confirm a diagnosis of AKI. We
only examined the specificity of the N17 code (acute
renal failure), and not other codes to which cases of AKI
may have been attributed (e.g. N19; unspecified kidney
failure). For a small proportion of the cases, patients did
not have AKI on admission but developed it subse-
quently during their hospital stay. Therefore, while we
considered whether the diagnostic criteria for AKI were
met at any time during the admission, the biochemical
changes may not be reflected in the admission character-
istics presented in this paper. We did not investigate the
incidence of AKI in patients who were not coded with
N17 and therefore cannot comment on the specificity or
sensitivity of the code for a diagnosis of AKI, or the
characteristics of cases of AKI that were not coded.
Acute kidney injury is often preventable, associated
with high healthcare costs and is an important risk fac-
tor for mortality [4]. Therefore, clear understanding of
the epidemiology of AKI is very important. The largest
studies of AKI incidence and outcomes have been based
on changes in serial creatinine measurements using the
‘Risk, Injury, Failure, Loss, End-Stage Renal Disease’ (RI-
FLE) and Acute Kidney Injury Network (AKIN) criteria
[19,20]. While biochemical and clinical definitions are
crucial for defining cases to examine AKI epidemiology,
they are associated with a number of problems. These
include the difficulty of defining baseline creatinine, dif-
ficulty in detecting additional cases defined only by a re-
duction in urine output and are subject to a number of
biases such as more frequent blood testing in unwell pa-
tients. In addition, these definitions cannot be used in
situations where limited biochemical data is available;
for example, pharmacoepidemiological studies in pri-
mary care outpatient databases. Therefore the use of ad-
ministrative coding data to examine AKI epidemiology
may be crucial in some situations. However, studies are
dependent on the validity of the coding and changes in
coding practice over time, and may underestimate inci-
dence if only more severe cases are coded [21].
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In a single large teaching hospital there was a 64% in-
crease in hospital admissions coded with acute renal fail-
ure as the primary or secondary diagnosis in 2010
compared to 2005. For both years, the patients were eld-
erly with a high level of co-morbidities and use of drugs
known to be associated with AKI. A detailed analysis of
a representative sample of these admissions found that
95% met international diagnostic criteria for AKI. Our
results demonstrate a high positive predictive value of
coding data for a clinical diagnosis of AKI, with no sug-
gestion (accepting the limitations of the study) of
marked changes in coding of AKI between 2005 and
2010.
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